122 related articles for article (PubMed ID: 12559132)
21. Regulation of hypothalamic signaling by tuberoinfundibular peptide of 39 residues is critical for the response to cold: a novel peptidergic mechanism of thermoregulation.
Dimitrov EL; Kim YY; Usdin TB
J Neurosci; 2011 Dec; 31(49):18166-79. PubMed ID: 22159128
[TBL] [Abstract][Full Text] [Related]
22. TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation.
Panda D; Goltzman D; Jüppner H; Karaplis AC
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1125-36. PubMed ID: 19706789
[TBL] [Abstract][Full Text] [Related]
23. Emerging functions for tuberoinfundibular peptide of 39 residues.
Usdin TB; Dobolyi A; Ueda H; Palkovits M
Trends Endocrinol Metab; 2003 Jan; 14(1):14-9. PubMed ID: 12475607
[TBL] [Abstract][Full Text] [Related]
24. Development of a rat parathyroid hormone 2 receptor antagonist.
Kuo J; Usdin TB
Peptides; 2007 Apr; 28(4):887-92. PubMed ID: 17207559
[TBL] [Abstract][Full Text] [Related]
25. Expression and distribution of tuberoinfundibular peptide of 39 residues in the rat central nervous system.
Dobolyi A; Palkovits M; Usdin TB
J Comp Neurol; 2003 Jan; 455(4):547-66. PubMed ID: 12508326
[TBL] [Abstract][Full Text] [Related]
26. Molecular determinants of tuberoinfundibular peptide of 39 residues (TIP39) selectivity for the parathyroid hormone-2 (PTH2) receptor. N-terminal truncation of TIP39 reverses PTH2 receptor/PTH1 receptor binding selectivity.
Hoare SR; Clark JA; Usdin TB
J Biol Chem; 2000 Sep; 275(35):27274-83. PubMed ID: 10854439
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of tuberoinfundibular peptide 38 and glucose-6-phosphatase in tilapia.
Shoemaker JM; Riley LG; Hirano T; Grau EG; Rubin DA
Gen Comp Endocrinol; 2006 Apr; 146(2):186-94. PubMed ID: 16375902
[TBL] [Abstract][Full Text] [Related]
28. High affinity binding of the peptide agonist TIP-39 to the parathyroid hormone 2 (PTH
Weaver RE; Mobarec JC; Wigglesworth MJ; Reynolds CA; Donnelly D
Biochem Pharmacol; 2017 Mar; 127():71-81. PubMed ID: 28012961
[TBL] [Abstract][Full Text] [Related]
29. Evidence for the expression of parathyroid hormone 2 receptor in the human brainstem.
Bagó AG; Palkovits M; Usdin TB; Seress L; Dobolyi A
Ideggyogy Sz; 2008 Mar; 61(3-4):123-6. PubMed ID: 18459453
[TBL] [Abstract][Full Text] [Related]
30. Neuropathic and inflammatory pain are modulated by tuberoinfundibular peptide of 39 residues.
Dimitrov EL; Kuo J; Kohno K; Usdin TB
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13156-61. PubMed ID: 23878240
[TBL] [Abstract][Full Text] [Related]
31. Activation of Parathyroid Hormone 2 Receptor Induces Decorin Expression and Promotes Wound Repair.
Sato E; Zhang LJ; Dorschner RA; Adase CA; Choudhury BP; Gallo RL
J Invest Dermatol; 2017 Aug; 137(8):1774-1783. PubMed ID: 28454729
[TBL] [Abstract][Full Text] [Related]
32. New members of the parathyroid hormone/parathyroid hormone receptor family: the parathyroid hormone 2 receptor and tuberoinfundibular peptide of 39 residues.
Usdin TB; Wang T; Hoare SR; Mezey E; Palkovits M
Front Neuroendocrinol; 2000 Oct; 21(4):349-83. PubMed ID: 11013069
[TBL] [Abstract][Full Text] [Related]
33. Tuberoinfundibular peptide of 39 residues: a new mediator of cardiac function via nitric oxide production in the rat heart.
Ross G; Engel P; Abdallah Y; Kummer W; Schluter KD
Endocrinology; 2005 May; 146(5):2221-8. PubMed ID: 15677763
[TBL] [Abstract][Full Text] [Related]
34. Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)/PTH-related peptide receptor, but functions as an antagonist.
Jonsson KB; John MR; Gensure RC; Gardella TJ; Jüppner H
Endocrinology; 2001 Feb; 142(2):704-9. PubMed ID: 11159842
[TBL] [Abstract][Full Text] [Related]
35. Postnatal development and gender-dependent expression of TIP39 in the rat brain.
Dobolyi A; Wang J; Irwin S; Usdin TB
J Comp Neurol; 2006 Sep; 498(3):375-89. PubMed ID: 16871538
[TBL] [Abstract][Full Text] [Related]
36. New Mechanisms of ECM Production during Wound Healing: A Role for Parathyroid Hormone 2 Receptor Signaling.
Wilgus TA
J Invest Dermatol; 2017 Aug; 137(8):1617-1619. PubMed ID: 28735615
[TBL] [Abstract][Full Text] [Related]
37. Vasodilatory effect of tuberoinfundibular peptide (TIP39): requirement of receptor desensitization and its beneficial effect in the post-ischemic heart.
Ross G; Heinemann MP; Schlüter KD
Peptides; 2007 Apr; 28(4):878-86. PubMed ID: 17222942
[TBL] [Abstract][Full Text] [Related]
38. Model of the complex of Parathyroid hormone-2 receptor and Tuberoinfundibular peptide of 39 residues.
Abraham-Nordling M; Persson B; Nordling E
BMC Res Notes; 2010 Oct; 3():270. PubMed ID: 20979597
[TBL] [Abstract][Full Text] [Related]
39. Structure of tuberoinfundibular peptide of 39 residues.
Piserchio A; Usdin T; Mierke DF
J Biol Chem; 2000 Sep; 275(35):27284-90. PubMed ID: 10856302
[TBL] [Abstract][Full Text] [Related]
40. PTH2 receptor-mediated inhibitory effect of parathyroid hormone and TIP39 on cell proliferation.
Misiano P; Scott BB; Scheideler MA; Garnier M
Eur J Pharmacol; 2003 May; 468(3):159-66. PubMed ID: 12754053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
